Transparency data

Non-tech summaries 2016: projects on regulatory uses

Projects granted during 2016 that have a primary purpose of regulatory purposes.


Non-technical summaries: projects granted in 2016, volume 14

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email Please tell us what format you need. It will help us if you say what assistive technology you use.


This document outlines the projects granted under the Animals (Scientific Procedures) Act 1986 during 2016 with a primary purpose of regulatory purposes.

The following projects were granted:

  • testing and development of vaccines/therapeutics (influenza-vaccines-therapeutics-efficacy)

  • therapeutic approaches to anticholinesterases (organophosphorus poisoning; therapeutics; regulatory submission)

  • efficacy pharmacology assessment - CNS (pharmacology, CNS, allergy, inflammation and nociception)

  • safety and quality control testing (pyrogen abnormal toxicity quality control)

  • regulatory testing using embryonating hen’s eggs (disinfectant, efficacy, extraneous, agents)

  • safety pharmacology (potential new medicine-safety, pharmacology, cardiovascular, central nervous system)

  • surgical alteration of animals for supply (surgery, animal, supply)

  • regulatory and investigative toxicology (medicine, safety, toxicity, toxicology)

  • batch potency and safety testing of foot and mouth disease (FMD) vaccine (potency safety FMD vaccine)

  • efficacy and safety of feed additives/ingredients (feed, efficacy, safety, farm animals)

  • transgenic mouse model for poliomyelitis (transgenic mouse, poliomyelitis, polio vaccines)

  • early safety assessments and follow-up investigatory studies (safety, pharmacology, drug development, physiology)

  • production of medical diagnostic reagents (blood, agar plates, vaccine production)

  • safety evaluation of substances administered to man (regulatory, toxicity, safety)

  • acute toxicology –chemicals (acute, toxicology, chemicals)

  • imaging agents - biodistribution for QC testing of ceretec (QC, batch release)

  • production of antibodies, antisera and blood products (antibodies, antisera, blood, antigen)

  • production of blood products for scientific use (blood, horse, sheep)

  • viral vaccines (batch release) (vaccine quality control, vaccine safety)

  • efficacy pharmacology assessments: circulatory, gastrointestinal and endocrine (pharmacology, circulatory, gastrointestinal, endocrine)

  • metabolism and pharmacokinetic studies (regulatory, metabolism, pharmacokinetic, animal)

  • coccidia control methods in poultry and game birds (coccidia, parasites, control)

  • reproduction toxicology studies (toxicology, safety, reproduction)

  • measuring the strength of immunological medicines (immunological, medicines, vaccines)

  • assessment of bioaccumulation in fish (bioaccumulation, regulatory, safety, chemical, pharmaceutical)

  • standards in virology (vaccine, virus, disease)

  • drug evaluation in pre-clinical oncology models (oncology, cancer, efficacy, combinations, pre-clinical)

  • regulatory ecotoxicology (ecotoxicology, regulatory, safety, chemical, pharmaceutical)

  • rodent toxicity, tumorigenicity and safety studies (regulatory, rodent, safety, toxicity, tumorigenicity)

  • antibody production for research, diagnosis and therapy (antibodies, sheep, goats, hens, donkeys)

  • toxicity in macaques by inhalation administration (pharmaceutical, regulatory, primate, inhalation)

Published 21 December 2017